[Critical analysis of the saralasintest in the diagnosis of hypertension (author's transl)].
The reliability of the angiotensin II (AT II)-antagonist Saralasin in the diagnosis of AT II-dependent forms of hypertension was investigated in 61 cases of hypertension of different etiology. In 14 patients, lowering of blood pressure by Saralasin suggested an AT II-dependent hypertension which could be ascertained in 8 patients (5 had undergone successful surgery) by increased levels of plasma-renin-activity (PRA), AT II, PRA-ratio in renal vein blood and by angiography. Besides, depressor reactions by Saralasin yielded additional information in three patients with renovascular hypertension but normal levels of PRA and AT II, in two patients with high renin essential hypertension and one patient with pheochromocytoma. This test seems to be valuable in the diagnosis of renin-dependent hypertension.
D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D003937:Diagnosis, Differential; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000209:etiology; D006977:Hypertension, Renal / Q000175:diagnosis; D008297:Male; D012083:Renin / Q000097:blood; D012504:Saralasin / Q000009:adverse effects / Q000494:pharmacology
D000804:Angiotensin II; D012083:Renin; D012504:Saralasin
Kritische Analyse des Saralasintestes in der Differentialdiagnostik der Hypertonie.